Content related to Fostering Innovation in Congenital Interventional Cardiology

A new clinical trial aims to shed light on how to best treat a patent ductus arteriosus in the most fragile infants.

A Children’s Hospital Los Angeles team has performed the first-in-human implant of a cardiac stent for babies that can be expanded to adult size as a child grows.

Here’s how the team performed the procedure, which spared a teen from open-heart surgery.

Combining expertise with ingenuity, a team of cardiovascular specialists fixes a rare heart defect in a premature baby.

The Ross procedure offers children the opportunity to have an aortic valve replacement that is their own valve: the pulmonary valve.

Team provides detailed diagnosis and seamless coordination for prenatal and postnatal care, as well as fetal cardiac interventions and leading-edge research.

Born at 25 weeks and just 2 pounds, Lincoln faces the precarious life of a micropreemie. But he has help—the vigilance of his parents and the expertise of multiple CHLA specialists.

In July 2015, Samantha and Marco Davila were at week 20 of their pregnancy, and they were excited to learn of their first child’s gender. But something was spotted on the ultrasound that would change

Even before Angelique Garcia was born, doctors at Children’s Hospital Los Angeles knew she had a severe form of congenital heart disease called complete atrioventricular canal defect (CAVC), thanks to